Cheryl R. Landman

Learn More
BACKGROUND Preoperative therapy with concurrent cisplatin infusion and accelerated hyperfractionated radiation has the potential to eradicate pools of resistant cells with high-growth fraction that accumulate during standard radiation therapy. Based on preliminary data showing a high complete response rate (necessary for organ preservation) in patients with(More)
Attached is the statement on the source of the data and accuracy of the estimates for the October 2006 CPS Microdata File on School Enrollment. If you have any questions or need additional information, please contact Amy Herron of the Demographic Statistical Methods Division via email at dsmd.source.and.accuracy@census.gov.
In most field surveys, the data collection process is observed only by the respondents and the interviewers. Others can observe only the traces reflected in the data and paradata. Careful selection and training of interviewers and thoughtful construction of the survey instrument are, of course, very important in maintaining data quality. But creating a(More)
BACKGROUND Stage III and IV squamous cell cancers of the head and neck are often unresectable at presentation and are associated with poor disease-free and overall survival rates. A phase II study using concurrent cisplatin and radiotherapy in advanced head and neck cancer indicated impressive local-regional control and survival with organ preservation. (More)